CTC and prostate cancer

30th October

AR-V7 Linked to Targeted Therapy Resistance in Prostate Cancer

Using the AdnaGen Test Emmanuel S. Antonarakis team at John associated the androgen receptor splice variant 7 with resistance to therapies for metastatic castration-resistant prostate cancer.

> Read more

> Learn more about the AdnaGen test for CTCs